LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Baseline identification of clonal V(D)J sequences for DNA-based minimal residual disease detection in multiple myeloma.

Even H Rustad / Malin Hultcrantz / Venkata D Yellapantula / Theresia Akhlaghi / Caleb Ho / Maria E Arcila / Mikhail Roshal / Akshar Patel / Denise Chen / Sean M Devlin / Austin Jacobsen / Ying Huang / Jeffrey E Miller / Elli Papaemmanuil / Ola Landgren

PLoS ONE, Vol 14, Iss 3, p e

2019  Volume 0211600

Abstract: Tracking of clonal immunoglobulin V(D)J rearrangement sequences by next generation sequencing is highly sensitive for minimal residual disease in multiple myeloma. However, previous studies have found variable rates of V(D)J sequence identification at ... ...

Abstract Tracking of clonal immunoglobulin V(D)J rearrangement sequences by next generation sequencing is highly sensitive for minimal residual disease in multiple myeloma. However, previous studies have found variable rates of V(D)J sequence identification at baseline, which could limit tracking. Here, we aimed to define the factors influencing the identification of clonal V(D)J sequences. Bone marrow mononuclear cells from 177 myeloma patients underwent V(D)J sequencing by the LymphoTrack assays (Invivoscribe). As a molecular control for tumor cell content, we sequenced the samples using our in-house myeloma panel myTYPE. V(D)J sequence clonality was identified in 81% of samples overall, as compared with 95% in samples where tumor-derived DNA was detectable by myTYPE. Clonality was detected more frequently in patients with lambda-restricted disease, mainly because of increased detection of kappa gene rearrangements. Finally, we describe how the tumor cell content of bone marrow aspirates decrease gradually in sequential pulls because of hemodilution: From the initial pull used for aspirate smear, to the final pull that is commonly used for research. In conclusion, baseline clonality detection rates of 95% or higher are feasible in multiple myeloma. Optimal performance depends on the use of good quality aspirates and/or subsequent tumor cell enrichment.
Keywords Medicine ; R ; Science ; Q
Subject code 610
Language English
Publishing date 2019-01-01T00:00:00Z
Publisher Public Library of Science (PLoS)
Document type Article ; Online
Database BASE - Bielefeld Academic Search Engine (life sciences selection)

More links

Kategorien

To top